Regulations.gov document
Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket…
Notice · FDA-2020-N-1440 · posted May 14, 2021
Key facts
| Document ID | FDA-2020-N-1440-0012 |
|---|---|
| Title | Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments |
| Document type | Notice |
| Subtype | Advisory Committee |
| Agency | FDA |
| Docket | FDA-2020-N-1440 |
| Posted | May 14, 2021 |
| Federal Register citation | 86 FR 26526 |
| FR document number | 2021-10181 |
| Comment period opens | May 14, 2021 |
| Comments due | Jun 24, 2021 |
| Effective date | May 14, 2021 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: